Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP) - PPP Study Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumabin patients with ...
Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumab in patients with moderate to severe palmoplantar pustular psoriasis (PPP) - PPP Study Uncontrolled, open Phase IIa study to investigate efficacy and safety of efalizumabin patients with ...
moderate to severe palmoplantar pustular psoriasis MedDRA version: 9.1;Level: LLT;Classification code 10037159;Term: Psoriasis pustular moderate to severe palmoplantar pustular psoriasis MedDRA version: 9.1;Level: LLT;Classification cod ...